中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 2-methylsulfanyl-[1,2,4]triazolo[1,5-a]quinazolin-5-one | 1354957-97-3 | C10H8N4OS | 232.266 |
The aim of this research was to study and evaluate the antimicrobial activity of a novel 2-methylsulfanyl-[1,2,4]triazolo[1,5-a]quinazoline and its derivatives. Antibacterial activity of the target compounds was tested against a variety of species of Gram-positive bacteria such as Staphylococcus aureus ATCC 29213, Bacillus subtilis ATCC6633, and Gram-negative bacteria such as Pseudomonas aeruginosa ATCC27953 and Escherichia coli ATCC 25922. In addition some yeast and fungi, Candida albicans NRRL Y-477 and Aspergillus niger, respectively, were screened.
Antimicrobial tests were carried out by the agar well diffusion method, using 100 μl of suspension containing 1 × 108 CFU/ml of pathological tested bacteria, 1 × 106 CFU/ml of yeast, and 1 × 104 spore/ml of fungi spread on nutrient agar (NA), Sabourand dextrose agar (SDA), and potato dextrose agar (PDA), respectively.
The minimum inhibitory concentration (MIC) of the tested compounds was determined using the broth double dilution method (serially diluted technique) in proper nutrient. For comparison, ciprofloxacin and ketoconazole were used as antibacterial and antifungal reference drugs, respectively. Compounds 6, 9, 13, 14, and 11 were found to have the highest broad-spectrum antibacterial activity against S. aureus ATCC 29213, B. subtilis ATCC6633 and Gram-negative bacteria such as P. aeruginosa ATCC27953 and E. coli ATCC 25922 with MIC values of 6.25 and 12.50 μg/ml.
It was clear that many of the synthesized compounds exhibited good antimicrobial activity. This study has revealed that compounds 6, 9, 13, 14, and 11 have been disclosed as moderate antimicrobial agents. These compounds could be useful as templates for further development through modification or derivatization to design more potent antimicrobial agents.
本研究的目的是研究和评估一种新型2-甲基硫基-[1,2,4]三唑并[1,5-a]喹唑啉及其衍生物的抗菌活性。目标化合物的抗菌活性针对多种革兰氏阳性细菌,如金黄色葡萄球菌ATCC 29213,枯草芽孢杆菌ATCC6633,以及革兰氏阴性细菌,如铜绿假单胞菌ATCC27953和大肠杆菌ATCC 25922进行了测试。此外,还对一些酵母菌和真菌,分别为白念珠菌NRRL Y-477和黑曲霉进行了筛选。
采用琼脂孔扩散法进行抗菌测试,使用含有1 × 10^8 CFU/ml病原菌、1 × 10^6 CFU/ml酵母菌和1 × 10^4 孢子/ml真菌的悬浮液100 μl分别涂布在营养琼脂(NA)、沙氏葡萄糖琼脂(SDA)和马铃薯葡萄糖琼脂(PDA)上。
通过在适当营养基中使用双倍稀释法(串联稀释技术)确定了被测试化合物的最小抑制浓度(MIC)。为了比较,分别使用环丙沙星和酮康唑作为抗菌和抗真菌参考药物。发现化合物6、9、13、14和11对金黄色葡萄球菌ATCC 29213、枯草芽孢杆菌ATCC6633以及革兰氏阴性细菌如铜绿假单胞菌ATCC27953和大肠杆菌ATCC 25922具有最高的广谱抗菌活性,MIC值为6.25和12.50 μg/ml。
许多合成化合物表现出良好的抗菌活性。本研究揭示了化合物6、9、13、14和11作为中等抗菌剂。这些化合物可以作为进一步开发的模板,通过修饰或衍生设计更有效的抗菌剂。